| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 720297 | Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate~ -3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spiro-1"-(4"-t-butyl)cyclohexane | 0.0435808621943462 | 0.09626987 |
| NSC 720299 | Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane | 0.0435808621943462 | 0.141786 |
| NSC 720386 | Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane | 0.0435808621943462 | 0.16384172 |
| NSC 722854 | 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline | 0.0435808621943462 | 0.22750692 |
| NSC 723732 | 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one | 0.0435808621943462 | 0.18961176 |
| NSC 728038 | 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline | 0.0435808621943462 | 0.59223633 |
| NSC 730868 | (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one | 0.0435808621943462 | 0.35943561 |
| NSC 732178 | Null | 0.0435808621943462 | 0.26520122 |
| NSC 735030 | Null | 0.0435808621943462 | 0.3235644 |
| NSC 736157 | Null | 0.0435808621943462 | 0.022500242 |